BG106700A - Sodium 2-(4,6-dimethylpyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl) ethoxy-3,3-diphenylpropionate and use thereof as endothelin antagonist - Google Patents
Sodium 2-(4,6-dimethylpyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl) ethoxy-3,3-diphenylpropionate and use thereof as endothelin antagonistInfo
- Publication number
- BG106700A BG106700A BG106700A BG10670002A BG106700A BG 106700 A BG106700 A BG 106700A BG 106700 A BG106700 A BG 106700A BG 10670002 A BG10670002 A BG 10670002A BG 106700 A BG106700 A BG 106700A
- Authority
- BG
- Bulgaria
- Prior art keywords
- diphenylpropionate
- dimethylpyrimidin
- dimethoxyphenyl
- yloxy
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Съединението има формула@@То е в твърда кристалнаформа. Изобретението се отнася и до използването на съединението като лекарствено средство.The compound has the formula It is in solid crystalline form. The invention also relates to the use of the compound as a medicament.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19951671A DE19951671A1 (en) | 1999-10-27 | 1999-10-27 | 2- (4,6-Dimethyl-pyrimidin-2-yloxy) -3- (2- (3,4-dimethoxyphenyl) ethoxy) -3,3-diphenylpropionic acid sodium salt and its use as an endothelin antagonist |
PCT/EP2000/010202 WO2001030767A1 (en) | 1999-10-27 | 2000-10-17 | Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106700A true BG106700A (en) | 2003-02-28 |
Family
ID=7927001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG106700A BG106700A (en) | 1999-10-27 | 2002-05-14 | Sodium 2-(4,6-dimethylpyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl) ethoxy-3,3-diphenylpropionate and use thereof as endothelin antagonist |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1228047A1 (en) |
JP (1) | JP2003512460A (en) |
KR (1) | KR20020047301A (en) |
CN (1) | CN1384822A (en) |
AU (1) | AU1272701A (en) |
BG (1) | BG106700A (en) |
BR (1) | BR0015112A (en) |
CA (1) | CA2389012A1 (en) |
CZ (1) | CZ20021485A3 (en) |
DE (1) | DE19951671A1 (en) |
HU (1) | HUP0203476A3 (en) |
IL (1) | IL149312A0 (en) |
MX (1) | MXPA02004071A (en) |
NO (1) | NO20021986L (en) |
SK (1) | SK5962002A3 (en) |
TR (1) | TR200201169T2 (en) |
WO (1) | WO2001030767A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ587551A (en) | 2004-06-24 | 2012-01-12 | Vertex Pharma | 5-Amino-phenol derivatives such as 5-amino-2,4-di-tert-butyl-phenol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19636046A1 (en) * | 1996-09-05 | 1998-03-12 | Basf Ag | New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists |
-
1999
- 1999-10-27 DE DE19951671A patent/DE19951671A1/en not_active Withdrawn
-
2000
- 2000-10-17 IL IL14931200A patent/IL149312A0/en unknown
- 2000-10-17 CN CN00814871A patent/CN1384822A/en active Pending
- 2000-10-17 MX MXPA02004071A patent/MXPA02004071A/en unknown
- 2000-10-17 WO PCT/EP2000/010202 patent/WO2001030767A1/en not_active Application Discontinuation
- 2000-10-17 SK SK596-2002A patent/SK5962002A3/en unknown
- 2000-10-17 JP JP2001533121A patent/JP2003512460A/en not_active Abandoned
- 2000-10-17 EP EP00974404A patent/EP1228047A1/en not_active Withdrawn
- 2000-10-17 CZ CZ20021485A patent/CZ20021485A3/en unknown
- 2000-10-17 TR TR2002/01169T patent/TR200201169T2/en unknown
- 2000-10-17 AU AU12727/01A patent/AU1272701A/en not_active Abandoned
- 2000-10-17 BR BR0015112-2A patent/BR0015112A/en not_active IP Right Cessation
- 2000-10-17 HU HU0203476A patent/HUP0203476A3/en unknown
- 2000-10-17 CA CA002389012A patent/CA2389012A1/en not_active Abandoned
- 2000-10-17 KR KR1020027005457A patent/KR20020047301A/en not_active Application Discontinuation
-
2002
- 2002-04-26 NO NO20021986A patent/NO20021986L/en not_active Application Discontinuation
- 2002-05-14 BG BG106700A patent/BG106700A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20021986D0 (en) | 2002-04-26 |
KR20020047301A (en) | 2002-06-21 |
TR200201169T2 (en) | 2002-09-23 |
HUP0203476A2 (en) | 2003-05-28 |
IL149312A0 (en) | 2002-11-10 |
CN1384822A (en) | 2002-12-11 |
AU1272701A (en) | 2001-05-08 |
HUP0203476A3 (en) | 2003-07-28 |
MXPA02004071A (en) | 2002-10-11 |
SK5962002A3 (en) | 2002-09-10 |
WO2001030767A1 (en) | 2001-05-03 |
JP2003512460A (en) | 2003-04-02 |
BR0015112A (en) | 2002-10-29 |
DE19951671A1 (en) | 2001-05-03 |
EP1228047A1 (en) | 2002-08-07 |
CZ20021485A3 (en) | 2003-06-18 |
NO20021986L (en) | 2002-04-26 |
CA2389012A1 (en) | 2001-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300877I2 (en) | obeticholic acid | |
PT1200426E (en) | TIENO-3-IL-SULFONYLAMINO (TIO) CARBONYL-TRIAZOLINE (TI) SUBSTITUTED ONES | |
TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
ATE297203T1 (en) | ANTITHRBOTIC AGENTS | |
EA200300717A1 (en) | Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands | |
EA200101232A1 (en) | PHENOXYPROPYLAMINE COMPOUNDS | |
PT1109812E (en) | PYRROLOBENZODIAZEPINAS | |
FR2805817B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION | |
EA200100971A1 (en) | NEW COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | |
EA200200873A1 (en) | NEW PIPERAZINE DERIVATIVES | |
EA200300528A1 (en) | 1-ARYL-OR 1-ALKYLSULPHONYLETHETROCYCLYLBENZAZOLES AS LIGANDS 5-HYDROXITRIPTAMINE-6 | |
EA200300919A1 (en) | N-SUBSTITUTED NON-ARYL HETEROCYCLIC ANTAGONISTS NMDA / NR2B | |
TR200400238T4 (en) | Alpha crystalline form of the perindopril tert-butylamine salt | |
BR0014651A (en) | Beta2-mediated cell adhesion inhibitors | |
BR0111913A (en) | Gabapentin analogs for sleep disorders | |
BR0209149A (en) | Phthalazinones | |
BR0108816A (en) | Quinoline derivatives as alpha-2 antagonists | |
EA200300716A1 (en) | HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6 | |
EA200200819A1 (en) | CRYSTAL FORM II LINEZOLIDE | |
SE9901077D0 (en) | Novel use | |
TR200000786T2 (en) | Vitronectin receptor antagonist | |
DE60112960D1 (en) | CONDENSED PYRIDOINDOL DERIVATIVES | |
EA200100297A1 (en) | ELECTRIPTANE HYDROBROMIDE MONOHYDRATE | |
TR200001909T2 (en) | Matrix metalloprosthesis inhibitors. | |
ATE308540T1 (en) | ANTITHROMBOTIC AGENTS |